$GV News

Visionary Holdings Inc. Announces Receipt of Nasdaq Delisting Determination Letter Related to Delinquent Listing Fees

Visionary Holdings Inc. Announces Receipt of Nasdaq Minimum Bid Price Notification

Visionary Holdings Receives Nasdaq Noncompliance Notification, Gets Time Through Oct. 5 To Regain Compliance

Visionary Holdings Inc. Announces Receipt of Nasdaq Continued Listing Deficiency Letter

Visionary Holdings Receives Deficiency Letter From Nasdaq

Visionary Holdings (GV) Stock Slides Over 21% Overnight As $20 Million Deal Rally Fades

Why Did Visionary Holdings (GV) Stock Soar 36% After Hours

Visionary Holdings Signs Cooperation Agreement with Strategic Investment Partner for Proposed US$20 Million Investment in Qingdao Anti-Aging Project

Visionary Holdings shares are trading higher after the company announced that it has entered into an investment cooperation agreement with Qingdao Xihai Rongke Enterprise Operation Management Co. for a proposed $20 million investment in the Qingdao anti-aging project.

Visionary Holdings shares are trading higher after the company announced that it has entered into an investment cooperation agreement with Qingdao Xihai Rongke Enterprise Operation Management Co. for a proposed $20 million investment in the Qingdao anti-aging project.

Visionary Holdings Enters Into Investment Cooperation Agreement With Qingdao Xihai For Proposed $20M Strategic Investment For Qingdao Anti-Aging Project In Qingdao West Coast New Area, China

Visionary Holdings Inc. (NASDAQ: GV) Enters into Strategic Cooperation Agreement to Expand Distribution Capabilities for Its V-Series Anti-Aging Products in China

Visionary Holdings Inks Agreement With Zhejiang Chushanji Digital Technology Over Marketing, Distribution, Sales Of V-Series Anti-Aging Products In China

UPDATE – Visionary Doubles Down on High-Margin Medical Aesthetics with US$12 Million Exclusive Agreement, Initiates Strategic Exit from Non-Core Businesses

UPDATE: Visionary Holdings Issues Update To Press Release Announced On March 2, 2026, Subsidiary Visionary Health Technology Signed $12M Distribution Agreement With Huajin China Investment

Visionary Holdings (NASDAQ: GV) Provides 2026–2027 Growth Outlook; RAMU Anti-Aging Product Line Targets Potential $30 Million Annual Sales

Visionary Holdings Targets Up To ~$30M Annual RAMU Anti-Aging Sales In 2026–2027 As It Continues The Expansion Into Global Healthcare And Medical Aesthetics Markets

Visionary Doubles Down on High-Margin Medical Aesthetics with US$12 Million Exclusive Agreement, Initiates Strategic Exit from Non-Core Businesses

Visionary Holdings Subsidiary Signs $12M Exclusive Distribution Agreement For Anti-Aging Product, Premier Regenerative Complex-President Super Injection, In Cooperation With Huajin China

Visionary Holdings Announces Continued Progress of Approximately US$9 Million Sales Contract